Anti-vascular endothelial growth factor for proliferative diabetic retinopathy - Test2 - elhamkhani - TriplyDB

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

http://www.wikidata.org/entity/Q24187858

about

Laser photocoagulation for proliferative diabetic retinopathy Neuroinflammatory responses in diabetic retinopathy Biomarkers in Diabetic Retinopathy The effect of intravitreal vascular endothelial growth factor on inner retinal oxygen delivery and metabolism in rats VEGF-B inhibits hyperglycemia- and Macugen-induced retinal apoptosis.Predictive factors of visual outcome of Malaysian cataract patients: a retrospective study.Identification of proteins associated with clinical and pathological features of proliferative diabetic retinopathy in vitreous and fibrovascular membranes.The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells.

P2860

Q24187871-79D32F38-DC86-47A6-98A2-ACBBC7E8B519 Q26798351-848D41BE-204F-47DA-A680-A69589A3C8F0 Q33583030-643E71F0-32AD-4078-9456-D04A95585BE9 Q36425846-2C5E2EFC-DEC2-4D8B-B79C-D7AF4014278A Q36911004-F06AD12B-657C-42F1-BC93-7BA3CDDD7CDD Q41697460-8AE02F27-E52D-45A9-9F10-D71D13D765A0 Q47130506-8CEEC5F0-3CFF-475A-944B-35A1BCA3EF69 Q48308877-E3C99814-132D-406F-8F0A-D5A4B1BE90DB Q55715276-07E9AC8A-2A61-4E7F-B8EB-4FE6BF4FDC2B

P2860

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

http://www.wikidata.org/entity/Q24187858

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@ast

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@en

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@en-gb

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@nl

type

label

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@ast

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@en

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@en-gb

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@nl

prefLabel

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@ast

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@en

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@en-gb

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@nl

P1433

Q24187858-607694BD-18A9-4BC1-8DE8-1CFDEE23B354

P1476

Q24187858-9EDFC305-9890-4D63-8F3E-9984BF33AD1E

P2093

Q24187858-21001510-7A8F-4726-A76A-2D4C3B85B3CC

Q24187858-97827901-8667-45EE-9682-A2A955E5616B

Q24187858-BE3C8B23-0DEB-4BB7-8D40-BF015B4B9A80

P2860

Q24187858-029752FB-7608-4649-A685-1E254E3CE35D

Q24187858-07BDCF56-29AA-4B0B-AF29-D340B7316C64

Q24187858-11A22578-CEA5-4D2A-9AEB-7A6134F675CA

Q24187858-12298D3E-FB0F-4E8C-BFF6-7A7A8B96F598

Q24187858-199566B9-5BD4-42A4-9071-EF378A47C739

Q24187858-1C497BEB-6160-476C-A221-5744CA178F54

Q24187858-24CBCDEF-DB32-4A6A-86B7-E51AC8943C81

Q24187858-284321E0-AF44-4B9B-9A6D-842F79BD2B03

Q24187858-2B1C405A-4094-4D2D-9F2A-26A9E14CD923

Q24187858-335B7507-5D46-40D6-AEED-0192847E29D4

P304

Q24187858-B7A72466-07E4-4062-9A6C-27BE2A93B38E

P31

Q24187858-2EA431E7-DF65-4200-94DC-0ACF241B7207

Q24187858-fd387437-2151-4dee-a184-fbebe08dd25d

P3181

Q24187858-9C4A5360-2A5E-4686-9D3B-857D862004C4

P356

Q24187858-E17553F7-37A5-4487-B229-EAA764E73B04

P433

Q24187858-0375F97E-597D-4D4F-9840-4A5E15640321

P50

Q24187858-1F63F0CA-F7D7-4131-8A79-CE261CA66502

Q24187858-4D1B26D1-72C1-4148-A74D-B58EF3D3090A

Q24187858-51B4D20E-9075-43FC-8997-1F1107143CDC

Q24187858-D9D4C9AA-E219-43B4-A7C2-B645B312968E

P577

Q24187858-2AA1D662-9A6F-4D59-8FFD-9B08155A71A1

P698

Q24187858-8945C12F-93AB-4B58-9C25-BF853449167D

P932

Q24187858-802B6A59-B795-494C-90E3-338D50D2657C

P3181

P356

14651858.CD008721.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

@en

P2093

Arturo J Martí-Carvajal

http://www.w3.org/2001/XMLSchema#string

José A Buil-Calvo

http://www.w3.org/2001/XMLSchema#string

José I Pijoán

http://www.w3.org/2001/XMLSchema#string

P2860

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema

Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy

Anti-vascular endothelial growth factor for proliferative diabetic retinopathy

Meta-analysis in clinical trials

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Panretinal photocoagulation versus PRP plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy (IBeHi study).

Intravitreal triamcinolone for refractory diabetic macular edema.

Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy.

P304

CD008721

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1564338

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD008721.PUB2

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer R. Evans

Mª José Martínez

P577

2014-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25418485

http://www.w3.org/2001/XMLSchema#string

P932

6995643

http://www.w3.org/2001/XMLSchema#string